Adaptive Biotechnologies (ADPT) Interest Expenses (2022 - 2026)

Adaptive Biotechnologies (ADPT) has 5 years of Interest Expenses data on file, last reported at $2.9 million in Q1 2026.

• Quarterly Interest Expenses fell 0.55% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (up 2.35% YoY) and the FY2025 annual result came in at $11.8 million, up 1.71% from the prior year.
• Interest Expenses eased to $2.9 million in Q1 2026 per ADPT's latest filing, from $3.0 million in the prior quarter.
• The five-year high for Interest Expenses was $3.7 million in Q3 2023, with the low at $653000.0 in Q3 2022.
• Average Interest Expenses over 5 years is $3.0 million, with a median of $3.0 million recorded in 2025.
• Year-over-year, Interest Expenses surged 459.26% in 2023 and decreased 25.21% in 2024.
• Adaptive Biotechnologies' Interest Expenses stood at $3.6 million in 2022, then retreated by 15.98% to $3.0 million in 2023, then dropped by 1.99% to $3.0 million in 2024, then grew by 0.07% to $3.0 million in 2025, then fell by 2.2% to $2.9 million in 2026.
• Business Quant data shows ADPT's Interest Expenses at $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.